RE: No dilution!!!14 Apr 2025 07:04
The Proposed Alliance: R42
The Company is in advanced discussions with R42 regarding a proposed alliance.
Through our proposed alliance with R42, we would offer a unique combination of resources, knowledge, and connections that position AI start-ups and projects for success.
Our proposed alliance with R42 would create a unique ecosystem for AI team members and innovators. Together, we would provide the resources, expertise, and network needed to transform ambitious ideas into companies aspiring to very significant valuations.
This proposed alliance would combine capAI's status as a publicly listed company, bringing market credibility, investor access, and financial resources, with R42's position as an AI powerhouse delivering cutting-edge research, technical expertise, and specialized infrastructure.
Through our proposed alliance with R42, we would target high-impact breakthroughs in media and medicine, sectors poised for exponential growth and disruption. This approach is designed to maximise both innovation and long-term value creation for our stakeholders.
As any agreement with R42 would constitute a material related party transaction for the purposes of DTR 7.3, the Company confirms that Professor Nag is abstaining from the Board's consideration of the partnership. Richard Edwards, Sarah Davy and Marcus Yeoman (in his capacity as the Company's independent director) will exercise their reasonable care, skill and diligence, to ensure that any agreement is fair and reasonable from the perspective of the Company and its shareholders who are not a related party (as such term is defined in UK-adopted International Financial Reporting Standards).
The Company will provide a further update regarding the proposed alliance with R42 as and when appropriate.